NORTHWEST BIOTHERAPEUTICS INC (NWBO) Operating margin 2016–2025
NORTHWEST BIOTHERAPEUTICS INC (NWBO) operating margin by fiscal year — reported operating income divided by reported revenue.
-4347.9%FY2025 · since FY2016: -12723.3% → -4347.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -4347.9% | +464.6 pp |
| FY2024 | -4812.4% | -1939.4 pp |
| FY2023 | -2873.1% | +1118.7 pp |
| FY2022 | -3991.7% | +1252.2 pp |
| FY2021 | -5244.0% | +1464.4 pp |
| FY2020 | -6708.4% | -5547.4 pp |
| FY2019 | -1161.0% | +8907.2 pp |
| FY2018 | -10068.2% | +6205.0 pp |
| FY2017 | -16273.2% | -3549.9 pp |
| FY2016 | -12723.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice